Deepening our understanding of the mechanism of action of tranexamic acid in TBI
Tranexamic acid prevents blood clots from breaking down and reduces bleeding. However, its role in traumatic brain injury remains uncertain. The CRASH-3 trial is a randomised trial that will examine the effect of tranexamic acid (versus placebo) on death and disability in 13,000 patients with traumatic brain injury.